These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19156888)

  • 61. Hints on the evolutionary design of a dimeric RNase with special bioactions.
    Di Donato A; Cafaro V; Romeo I; D'Alessio G
    Protein Sci; 1995 Aug; 4(8):1470-7. PubMed ID: 8520472
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dynamics of ribonuclease A and ribonuclease S: computational and experimental studies.
    Nadig G; Ratnaparkhi GS; Varadarajan R; Vishveshwara S
    Protein Sci; 1996 Oct; 5(10):2104-14. PubMed ID: 8897611
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protein engineering of ribonucleases.
    Cafaro V; Bracale A; Formiggini F; Notomista E; D'Alessio G; Di Donato A
    Biochimie; 1998 Nov; 80(11):905-9. PubMed ID: 9893950
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Contribution of electrostatics to the binding of pancreatic-type ribonucleases to membranes.
    Sundlass NK; Eller CH; Cui Q; Raines RT
    Biochemistry; 2013 Sep; 52(37):6304-12. PubMed ID: 23947917
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reversible substrate-induced domain motions in ribonuclease A.
    Vitagliano L; Merlino A; Zagari A; Mazzarella L
    Proteins; 2002 Jan; 46(1):97-104. PubMed ID: 11746706
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells.
    Piccoli R; Di Gaetano S; De Lorenzo C; Grauso M; Monaco C; Spalletti-Cernia D; Laccetti P; Cinátl J; Matousek J; D'Alessio G
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7768-73. PubMed ID: 10393896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Localization and analysis of nonpolar regions in onconase.
    Kolbanovskaya EY; Terwisscha van Scheltinga AC; Mukhortov VG; Ardelt W; Beintema JJ; Karpeisky MY
    Cell Mol Life Sci; 2000 Aug; 57(8-9):1306-16. PubMed ID: 11028920
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Ribonucleases as antiviral agents].
    Il'inskaia ON; Shakh Makhmud R
    Mol Biol (Mosk); 2014; 48(5):707-17. PubMed ID: 25842855
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protein interactions of dirhodium tetraacetate: a structural study.
    Ferraro G; Pratesi A; Messori L; Merlino A
    Dalton Trans; 2020 Feb; 49(8):2412-2416. PubMed ID: 32022076
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Native-state hydrogen-exchange studies of a fragment complex can provide structural information about the isolated fragments.
    Chakshusmathi G; Ratnaparkhi GS; Madhu PK; Varadarajan R
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7899-904. PubMed ID: 10393919
    [TBL] [Abstract][Full Text] [Related]  

  • 71. How good are comparative models in the understanding of protein dynamics?
    Yazhini A; Srinivasan N
    Proteins; 2020 Jul; 88(7):874-888. PubMed ID: 31999374
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Formation and properties of S-protein complex with S-peptide-containing fusion protein.
    Karpeisky MYa ; Senchenko VN; Dianova MV; Kanevsky VYu
    FEBS Lett; 1994 Feb; 339(3):209-12. PubMed ID: 8112457
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The role of the hinge loop in domain swapping. The special case of bovine seminal ribonuclease.
    Picone D; Di Fiore A; Ercole C; Franzese M; Sica F; Tomaselli S; Mazzarella L
    J Biol Chem; 2005 Apr; 280(14):13771-8. PubMed ID: 15647261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cisplatin binding to proteins: molecular structure of the ribonuclease a adduct.
    Messori L; Merlino A
    Inorg Chem; 2014 Apr; 53(8):3929-31. PubMed ID: 24694179
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Endocytotic internalization as a crucial factor for the cytotoxicity of ribonucleases.
    Leich F; Stöhr N; Rietz A; Ulbrich-Hofmann R; Arnold U
    J Biol Chem; 2007 Sep; 282(38):27640-6. PubMed ID: 17635931
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Changing the net charge from negative to positive makes ribonuclease Sa cytotoxic.
    Ilinskaya ON; Dreyer F; Mitkevich VA; Shaw KL; Pace CN; Makarov AA
    Protein Sci; 2002 Oct; 11(10):2522-5. PubMed ID: 12237473
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structural basis for the regulation of enzymatic activity of Regnase-1 by domain-domain interactions.
    Yokogawa M; Tsushima T; Noda NN; Kumeta H; Enokizono Y; Yamashita K; Standley DM; Takeuchi O; Akira S; Inagaki F
    Sci Rep; 2016 Mar; 6():22324. PubMed ID: 26927947
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A nucleophile activation dyad in ribonucleases. A combined X-ray crystallographic/ab initio quantum chemical study.
    Mignon P; Steyaert J; Loris R; Geerlings P; Loverix S
    J Biol Chem; 2002 Sep; 277(39):36770-4. PubMed ID: 12122018
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human RNase 1 can extensively oligomerize through 3D domain swapping thanks to the crucial contribution of its C-terminus.
    Noro I; Bettin I; Fasoli S; Smania M; Lunardi L; Giannini M; Andreoni L; Montioli R; Gotte G
    Int J Biol Macromol; 2023 Sep; 249():126110. PubMed ID: 37536419
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design and characterization of an HIV-specific ribonuclease zymogen.
    Turcotte RF; Raines RT
    AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1357-63. PubMed ID: 19025416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.